RIPK7 mutations and kinase activity play very important roles in the pathogenesis of PD (Berwick et al., 2019; Seegobin et al., 2020), whereas RIPK7 is expressed at low levels in neurons but at high levels in immune cells. The gene discussed is LRRK2; the disease is Parkinson disease.